Cypress Bioscience, Inc. to Present at Citi's 4th Annual Biotech Day

• Press Release
• Source: Cypress Bioscience, Inc.
• On 6:30 am EDT, Monday March 30, 2009

SAN DIEGO, CA--(MARKET WIRE)--Mar 30, 2009 -- Cypress Bioscience, Inc. (NasdaqGM:CYPB - News) today announced that Michael R. Hufford, PhD, its Vice President of Corporate Development, will present at Citi's 4th Annual Biotech Day on April 1, 2009.

Related Quotes

Symbol	Price	Change
CYPB	5.40	+0.12

{"s" : "cypb","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The Citi conference is being held in New York City. Dr. Hufford is scheduled to present on Wednesday, April 1st at 10:00 a.m. Eastern Time. The audio broadcast of this presentation can be accessed at http://www.veracast.com/webcasts/citigroup/biotech09/29103305.cfm.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/events.php.

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella(TM) (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

     For additional information please contact
      
     Mary Gieson
     Investor Relations
     (858) 452-2323
     Email Contact